GRIA1 and early-onset autosomal dominant Alzheimer disease: Furthermore, the Apaf1 inhibitor has been used to confirm the effect of caspase-3 inhibition on GluR1 synaptic distribution in a mouse model of Alzheimer’s disease (D’Amelio et al., 2011).